NDC 16714-534 – Emtricitabine and tenofovir disoproxil fumarate

Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC16714-534

Product details

Brand name
Emtricitabine and tenofovir disoproxil fumarate
Generic name
Emtricitabine and tenofovir disoproxil fumarate
Labeler
NorthStar RxLLC
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA203442
Marketed since
March 9, 2022
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (1)

Package NDCDescriptionSince
16714-534-0130 TABLET, FILM COATED in 1 BOTTLE (16714-534-01)Mar 9, 2022

Other Emtricitabine and tenofovir disoproxil fumarate products